Bicycle Therapeutics PLC expected to post a loss of 61 cents a share - Earnings Preview

Bicycle Therapeutics

01/11/2021 18:21

* Bicycle Therapeutics PLC  BCYC.OQ   BCYC.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 3 (estimated). 
* The Cambridge, Cambridgeshire-based company is expected to
report  a 15.4% increase in revenue to $4.433 million from $3.84
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Bicycle Therapeutics
PLC is for a loss of 61 cents per share. For the same quarter
last year, the company reported a loss of 52 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $68.5​, about 25% above​ its last closing
price of $51.40. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.68       -0.73      -0.74     Missed  -1.9
 Mar. 312021   -0.73       -0.71      -0.73     Missed  -3.3
 Dec. 312020   -0.54       -0.47      -0.83     Missed  -75.7​
 Sep. 302020   -0.51       -0.52      -0.52     Met     -0.5
 ​​Jun.        -0.51       -0.48      -0.67     Missed  -40.8
 302020                                                 
 Mar. 312020   0.04        0.11       -0.63     Missed  -672.7
                                                        ​
 Dec. 312019   -0.47       -0.52      -0.25     Beat    52.3
 Sep. 302019   -0.57       -0.58      -0.53     Beat    8.2
 This summary was machine generated November 1 at 18:21 GMT.  All
figures in US dollars unless otherwise stated